サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1193103

血管塞栓術の製品別、用途別、エンドユーザー別市場：世界の機会分析および産業予測、2021-2031年

Vascular Embolization Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 282 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血管塞栓術の製品別、用途別、エンドユーザー別市場：世界の機会分析および産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 282 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血管塞栓術の世界市場は、2021年に36億8,273万米ドルとなり、2022年から2031年にかけてCAGR7.7%で成長し、2031年には77億8,098万米ドルに達すると予測されます。

塞栓術と呼ばれる低侵襲なプロセスにより、特定の場所の血流を抑制します。この処置は、周囲の正常な血流を維持しながら行われ、組織を保護しながら問題となる出血に対処します。血管が詰まることを塞栓症といい、医学的な理由で意図的に血管を塞ぐことを塞栓術といいます。コイル塞栓術と呼ばれるカテーテルを用いた治療法は、動脈内の異常な血流を正確に塞ぐことができます。金属製の閉塞コイルを装着したカテーテルを用いて、通常鼠径部にある動脈（大腿動脈）に挿入します。

そして、前進によって異常血管に到達します。血流とともに前進し、カテーテルやコイルが届かないような場所まで血管床の奥深くまで入り込むことで、液体塞栓剤は標的血管を満たし、血管の閉塞を引き起こす能力を持つのです。着脱式バルーンは、他の塞栓術に比べて、バルーンを取り外すまで塞栓が可逆的であるという利点があります。大きな動脈や瘻孔を瞬時に、かつ正確に閉塞することができます。世界の血管塞栓市場の成長は、血管疾患の有病率の驚くべき増加によって主に駆動されています。塞栓技術や製品による血管疾患治療の改善の増加はまた、血管塞栓市場の成長を加速させる。

また、血管閉塞のための非侵襲的な手順における塞栓の成功率の増加、従来の手順やこれの他の技術の進歩への実行可能な代替手段としての可用性は、さらに市場を駆動すると予想されています。一例を挙げると、セント・ジュード・メディカル社のアンプラッツァー・プラグ4は、市場で容易に入手可能です。しかし、血管塞栓術の費用が高いこと、それに伴う合併症があることが、市場の成長を妨げています。また、がん治療においては、化学療法や放射線療法などの治療法が好まれるが、これは、従来のがん治療法が一般に認知されていること、先進的な治療法が普及していないこと、腫瘍医が従来の治療法からの転換に消極的であることなどが理由です。また、塞栓剤を誤った場所に留置してしまうと、正常な組織から酸素を奪ってしまう危険性があります。これらは、市場の成長にマイナスの影響を与える要因となっています。

世界の血管塞栓術市場は、製品、用途、エンドユーザーに区分されます。製品別では、塞栓剤と塞栓用デバイスに分類されます。塞栓剤と塞栓デバイスは、さらに液体塞栓剤とマイクロスフィアに細分化されます。そして、塞栓デバイスは、コイル、着脱式バルーン、塞栓プラグ、サポートデバイスに分類されます。

アプリケーション別に見ると、市場は腫瘍、末梢血管疾患、泌尿器・腎臓、神経、その他に分別されます。エンドユーザー別では、病院・診療所、外来手術センター、その他に区分されます。地域別市場は、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、および欧州の残りの部分）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、およびアジア太平洋の残りの部分）、およびLAMEA（ブラジル、南アフリカ、サウジアラビア、およびLAMEAの残り）にわたって分析されています。世界の血管塞栓市場で動作主な選手はアボット研究所です,Balt Group、Boston Scientific Corporation、Cook Medical、Johnson and Johnson、Kaneka Corporation、Medtronic Plc、Merit Medical、Stryker Corporation、およびTerumo Medical Corporationがあります。

利害関係者にとっての主なメリット

  • 当レポートでは、2021年から2031年までの血管塞栓術市場分析の市場セグメント、現在の動向、推定、力学を定量的に分析し、優勢な血管塞栓術市場の機会を特定します。
  • 市場調査は、主要な促進要因、市場抑制要因、機会に関連する情報とともに提供されます。
  • ポーターのファイブフォース分析では、利害関係者が利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの効力を強調します。
  • 血管塞栓術市場のセグメンテーションの詳細な分析は、一般的な市場機会を決定するのに役立ちます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場プレイヤーのポジショニングは、ベンチマークを容易にし、市場プレイヤーの現在の位置の明確な理解を提供します。
  • 当レポートでは、地域および世界の血管塞栓術の市場動向、主要企業、市場セグメント、応用分野、市場成長戦略に関する分析を掲載しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 血管塞栓術市場：製品別

  • 概要
    • 市場規模および予測
  • 塞栓剤
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別分析
    • 塞栓剤血管塞栓術市場：タイプ別
      • 液状塞栓剤の市場規模及び予測：地域別
      • マイクロスフェアーの市場規模及び予測：地域別
  • 塞栓用デバイス
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
    • 塞栓器具血管塞栓術市場：タイプ別
      • コイル市場規模・予測：地域別
      • 取り外し可能なバルーン市場規模・予測：地域別
      • 塞栓用プラグの市場規模・予測：地域別
      • サポートデバイスの市場規模・予測：地域別

第5章 血管塞栓術市場：適用分野別

  • 概要
    • 市場規模・予測
  • オンコロジー
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 末梢血管疾患
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 泌尿器科・腎臓内科
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 神経学
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第6章 血管塞栓術市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 病院とクリニック
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 外来手術センター
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第7章 血管塞栓術市場： 地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米の市場規模・予測：製品別
      • 北米の塞栓剤・血管塞栓術市場：タイプ別
      • 北米の血管塞栓術用デバイス市場：タイプ別
    • 北米市場規模・予測：用途別
    • 北米市場規模・予測：エンドユーザー別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州の市場規模・予測：製品別
      • 欧州の塞栓剤血管塞栓術市場：タイプ別
      • 欧州の血管塞栓術用デバイス市場：タイプ別
    • 欧州市場規模・予測：アプリケーション別
    • 欧州市場規模・予測：エンドユーザー別
    • 欧州市場規模・予測：国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他の欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：製品別
      • アジア太平洋地域の塞栓剤血管塞栓術市場：タイプ別
      • アジア太平洋地域の血管塞栓術用デバイス市場：タイプ別
    • アジア太平洋地域血管塞栓術市場規模・予測：用途別
    • アジア太平洋地域の血管塞栓術の市場規模・予測：エンドユーザー別
    • アジア太平洋地域の市場規模・予測：国別
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：製品別
      • LAMEA塞栓剤血管塞栓術市場：タイプ別
      • LAMEA血管塞栓術用デバイス市場：タイプ別
    • LAMEA血管塞栓術の市場規模・予測：用途別
    • LAMEAの市場規模・予測：エンドユーザー別
    • LAMEAの市場規模・予測：国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ共和国
      • その他のLAMEA地域

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • BOSTON SCIENTIFIC CORPORATION
  • MERIT MEDICAL SYSTEMS
  • TERUMO CORPORATION
  • MEDTRONIC PLC
  • ABBOTT LABORATORIES
  • DEPUY SYNTHES（J&J MEDICAL DEVICES）
  • COOK MEDICAL
  • BALT
  • KANEKA CORPORATION
  • STRYKER CORPORATION
図表

LIST OF TABLES

  • TABLE 1. GLOBAL VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 2. VASCULAR EMBOLIZATION MARKET, FOR EMBOLIC AGENTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. VASCULAR EMBOLIZATION MARKET FOR EMBOLIC AGENTS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 5. VASCULAR EMBOLIZATION MARKET, FOR LIQUID EMBOLIC AGENTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. VASCULAR EMBOLIZATION MARKET, FOR MICROSPHERES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. VASCULAR EMBOLIZATION MARKET, FOR EMBOLIZATION DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. VASCULAR EMBOLIZATION MARKET FOR EMBOLIZATION DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 9. GLOBAL EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 10. VASCULAR EMBOLIZATION MARKET, FOR COILS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. VASCULAR EMBOLIZATION MARKET, FOR DETACHABLE BALLOONS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. VASCULAR EMBOLIZATION MARKET, FOR EMBOLIC PLUG, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. VASCULAR EMBOLIZATION MARKET, FOR SUPPORT DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. GLOBAL VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 15. VASCULAR EMBOLIZATION MARKET, FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. VASCULAR EMBOLIZATION MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. VASCULAR EMBOLIZATION MARKET, FOR PERIPHERAL VASCULAR DISEASES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. VASCULAR EMBOLIZATION MARKET FOR PERIPHERAL VASCULAR DISEASES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 19. VASCULAR EMBOLIZATION MARKET, FOR UROLOGY AND NEPHROLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. VASCULAR EMBOLIZATION MARKET FOR UROLOGY AND NEPHROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. VASCULAR EMBOLIZATION MARKET, FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. VASCULAR EMBOLIZATION MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. VASCULAR EMBOLIZATION MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. VASCULAR EMBOLIZATION MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. GLOBAL VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 26. VASCULAR EMBOLIZATION MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 27. VASCULAR EMBOLIZATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 28. VASCULAR EMBOLIZATION MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 29. VASCULAR EMBOLIZATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. VASCULAR EMBOLIZATION MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 31. VASCULAR EMBOLIZATION MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. VASCULAR EMBOLIZATION MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 33. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 34. NORTH AMERICA EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 35. NORTH AMERICA EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 36. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 37. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 39. U.S. VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 40. U.S. VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 41. U.S. VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. CANADA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 43. CANADA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 44. CANADA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. MEXICO VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 46. MEXICO VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. MEXICO VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. EUROPE VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 49. EUROPE EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 50. EUROPE EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 51. EUROPE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 52. EUROPE VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 53. EUROPE VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 54. GERMANY VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 55. GERMANY VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 56. GERMANY VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. FRANCE VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 58. FRANCE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. FRANCE VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 60. UK VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 61. UK VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 62. UK VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 63. ITALY VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 64. ITALY VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 65. ITALY VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 66. SPAIN VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 67. SPAIN VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 68. SPAIN VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 69. REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 70. REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 71. REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 72. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 73. ASIA-PACIFIC EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 74. ASIA-PACIFIC EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 75. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 78. CHINA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 79. CHINA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 80. CHINA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. JAPAN VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 82. JAPAN VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 83. JAPAN VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 84. INDIA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 85. INDIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 86. INDIA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 87. AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 88. AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 89. AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 90. SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 91. SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 94. REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 96. LAMEA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 97. LAMEA EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 98. LAMEA EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 99. LAMEA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 100. LAMEA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 101. LAMEA VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 102. BRAZIL VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 103. BRAZIL VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 104. BRAZIL VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 105. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 106. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 107. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 108. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 109. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 110. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 111. REST OF LAMEA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 112. REST OF LAMEA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 113. REST OF LAMEA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 114.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 115.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 116.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 117.BOSTON SCIENTIFIC CORPORATION: NET SALES,
  • TABLE 118.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 119.MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • TABLE 120.MERIT MEDICAL SYSTEMS: OPERATING SEGMENTS
  • TABLE 121.MERIT MEDICAL SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 122.MERIT MEDICAL SYSTEMS: NET SALES,
  • TABLE 123.MERIT MEDICAL SYSTEMS: KEY STRATERGIES
  • TABLE 124.TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 125.TERUMO CORPORATION: OPERATING SEGMENTS
  • TABLE 126.TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 127.TERUMO CORPORATION: NET SALES,
  • TABLE 128.TERUMO CORPORATION: KEY STRATERGIES
  • TABLE 129.MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 130.MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 131.MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 132.MEDTRONIC PLC: NET SALES,
  • TABLE 133.MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 134.ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 135.ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 136.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 137.ABBOTT LABORATORIES: NET SALES,
  • TABLE 138.ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 139.DEPUY SYNTHES (J&J MEDICAL DEVICES): COMPANY SNAPSHOT
  • TABLE 140.DEPUY SYNTHES (J&J MEDICAL DEVICES): OPERATING SEGMENTS
  • TABLE 141.DEPUY SYNTHES (J&J MEDICAL DEVICES): PRODUCT PORTFOLIO
  • TABLE 142.DEPUY SYNTHES (J&J MEDICAL DEVICES): NET SALES,
  • TABLE 143.DEPUY SYNTHES (J&J MEDICAL DEVICES): KEY STRATERGIES
  • TABLE 144.COOK MEDICAL: COMPANY SNAPSHOT
  • TABLE 145.COOK MEDICAL: OPERATING SEGMENTS
  • TABLE 146.COOK MEDICAL: PRODUCT PORTFOLIO
  • TABLE 147.COOK MEDICAL: NET SALES,
  • TABLE 148.COOK MEDICAL: KEY STRATERGIES
  • TABLE 149.BALT: COMPANY SNAPSHOT
  • TABLE 150.BALT: OPERATING SEGMENTS
  • TABLE 151.BALT: PRODUCT PORTFOLIO
  • TABLE 152.BALT: NET SALES,
  • TABLE 153.BALT: KEY STRATERGIES
  • TABLE 154.KANEKA CORPORATION: COMPANY SNAPSHOT
  • TABLE 155.KANEKA CORPORATION: OPERATING SEGMENTS
  • TABLE 156.KANEKA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 157.KANEKA CORPORATION: NET SALES,
  • TABLE 158.KANEKA CORPORATION: KEY STRATERGIES
  • TABLE 159.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 160.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 161.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 162.STRYKER CORPORATION: NET SALES,
  • TABLE 163.STRYKER CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.VASCULAR EMBOLIZATION MARKET SEGMENTATION
  • FIGURE 2.VASCULAR EMBOLIZATION MARKET,2021-2031
  • FIGURE 3.VASCULAR EMBOLIZATION MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.VASCULAR EMBOLIZATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.VASCULAR EMBOLIZATION MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 15.VASCULAR EMBOLIZATION MARKET,BY APPLICATION,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ONCOLOGY VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PERIPHERAL VASCULAR DISEASES VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF UROLOGY AND NEPHROLOGY VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF NEUROLOGY VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 21.VASCULAR EMBOLIZATION MARKET,BY END USER,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
  • FIGURE 25.VASCULAR EMBOLIZATION MARKET BY REGION,2021
  • FIGURE 26.U.S. VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 27.CANADA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 28.MEXICO VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 29.GERMANY VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 30.FRANCE VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 31.UK VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 32.ITALY VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 33.SPAIN VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 34.REST OF EUROPE VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 35.CHINA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 36.JAPAN VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 37.INDIA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 38.AUSTRALIA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 39.SOUTH KOREA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 41.BRAZIL VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 42.SAUDI ARABIA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH AFRICA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF LAMEA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49.COMPETITIVE DASHBOARD
  • FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 51.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 52.MERIT MEDICAL SYSTEMS.: NET SALES ,($MILLION)
  • FIGURE 53.TERUMO CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 54.MEDTRONIC PLC.: NET SALES ,($MILLION)
  • FIGURE 55.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 56.DEPUY SYNTHES (J&J MEDICAL DEVICES).: NET SALES ,($MILLION)
  • FIGURE 57.COOK MEDICAL.: NET SALES ,($MILLION)
  • FIGURE 58.BALT.: NET SALES ,($MILLION)
  • FIGURE 59.KANEKA CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 60.STRYKER CORPORATION.: NET SALES ,($MILLION)
目次
Product Code: A13246

The global vascular embolization market was valued at $3,682.73 million in 2021, and is projected to reach $7,780.98 million by 2031, registering a CAGR of 7.7% from 2022 to 2031. 

A minimally invasive process called embolization inhibits blood flow in certain places. The procedure is carried out while preserving regular blood flow in the surrounding areas to protect tissues while managing problematic bleeding. When a blood vessel becomes blocked, it is called an embolism, and when a blood vessel is purposefully blocked for medical reasons, it is called an embolization operation. A catheter-based technique called coil embolization enables exact blockage of aberrant blood flow in a blood artery. An artery, typically in the groin, is entered using a catheter with a metallic occluding coil (the femoral artery). 

The aberrant blood vessel is then reached by the advancement. By moving forward with blood flow and penetrating deeper into the vascular bed to locations where a catheter or coil may not reach, liquid embolic agents have the capacity to fill the target vessel and cause vascular blockage. Detachable balloons have an advantage over other embolization techniques such as embolization through detachable balloons is reversible until the balloon is removed. Large arteries and fistulae can be instantly and precisely occluded .The growth of global vascular embolization market is majorly driven by an alarming increase in prevalence of vascular diseases. Increase in improvements in vascular disease treatment by embolization techniques and products also accelerates the growth of the vascular embolization market. 

Moreover, increased success rate of embolization plugs in non-invasive procedures for vascular occlusion, its availability as a viable alternative to conventional procedure and other technological advancement in this is anticipated to drive the market even more. To site an example, the Amplatzer Plug 4 by St. Jude Medical, Inc. is easily available in the market. However, high cost of vascular embolization, complications associated with it, hinders the growth of the market. In addition, therapies like chemotherapy, and radiation therapy are preferred options in the treatment of cancer because people are generally aware of traditional cancer treatments, advanced treatment options are not widely used and oncologists are reluctant to switch from traditional treatment options. In addition, risk of lodging an embolic agent in the wrong place can deprive normal tissues of oxygen. These are the factors which will negatively impact the growth of the market.

The global vascular embolization market is segmented into product, application, and end user. By product, the market is categorized into embolic agents and embolization devices. Embolic agents and Embolic Devices are further sub categorized into liquid embolic agents and microspheres. And embolization devices are classified into coils, detachable balloons, embolic plugs, and support devices. 

On the basis of application, the market is segregated into oncology, peripheral vascular diseases, urology and nephrology, neurology and others. On the basis of end user, the market is segmented into hospitals & clinics, ambulatory surgical centers and others. By region market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).Major key players that operate in the global vascular embolization market are Abbott Laboratories., Balt Group, Boston Scientific Corporation, Cook Medical, Johnson and Johnson, Kaneka Corporation, Medtronic Plc, Merit Medical, Stryker Corporation, and Terumo Medical Corporation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vascular embolization market analysis from 2021 to 2031 to identify the prevailing vascular embolization market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the vascular embolization market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global vascular embolization market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Embolic Agents
    • Type
    • Liquid Embolic Agents
    • Microspheres
  • Embolization Devices
    • Type
    • Coils
    • Detachable Balloons
    • Embolic Plug
    • Support Devices

By Application

  • Oncology
  • Peripheral Vascular Diseases
  • Urology and Nephrology
  • Neurology
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • BOSTON SCIENTIFIC CORPORATION
    • MERIT MEDICAL SYSTEMS
    • TERUMO CORPORATION
    • MEDTRONIC PLC
    • ABBOTT LABORATORIES
    • DEPUY SYNTHES (J&J MEDICAL DEVICES)
    • COOK MEDICAL
    • BALT
    • KANEKA CORPORATION
    • STRYKER CORPORATION

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: VASCULAR EMBOLIZATION MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Embolic Agents
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Embolic Agents Vascular Embolization Market by Type
      • 4.2.4.1 Liquid Embolic Agents Market size and forecast, by region
      • 4.2.4.2 Microspheres Market size and forecast, by region
  • 4.3 Embolization Devices
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
    • 4.3.4 Embolization Devices Vascular Embolization Market by Type
      • 4.3.4.1 Coils Market size and forecast, by region
      • 4.3.4.2 Detachable Balloons Market size and forecast, by region
      • 4.3.4.3 Embolic Plug Market size and forecast, by region
      • 4.3.4.4 Support Devices Market size and forecast, by region

CHAPTER 5: VASCULAR EMBOLIZATION MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Oncology
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Peripheral Vascular Diseases
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Urology and Nephrology
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Neurology
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country
  • 5.6 Others
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market analysis by country

CHAPTER 6: VASCULAR EMBOLIZATION MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals and Clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: VASCULAR EMBOLIZATION MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
      • 7.2.2.1 North America Embolic Agents Vascular Embolization Market by Type
      • 7.2.2.2 North America Embolization Devices Vascular Embolization Market by Type
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
      • 7.3.2.1 Europe Embolic Agents Vascular Embolization Market by Type
      • 7.3.2.2 Europe Embolization Devices Vascular Embolization Market by Type
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Product
      • 7.3.5.5.2 Market size and forecast, by Application
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Product
      • 7.3.5.6.2 Market size and forecast, by Application
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
      • 7.4.2.1 Asia-Pacific Embolic Agents Vascular Embolization Market by Type
      • 7.4.2.2 Asia-Pacific Embolization Devices Vascular Embolization Market by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Product
      • 7.4.5.6.2 Market size and forecast, by Application
      • 7.4.5.6.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
      • 7.5.2.1 LAMEA Embolic Agents Vascular Embolization Market by Type
      • 7.5.2.2 LAMEA Embolization Devices Vascular Embolization Market by Type
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Application
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Application
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 BOSTON SCIENTIFIC CORPORATION
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 MERIT MEDICAL SYSTEMS
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 TERUMO CORPORATION
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 MEDTRONIC PLC
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 ABBOTT LABORATORIES
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 DEPUY SYNTHES (J&J MEDICAL DEVICES)
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 COOK MEDICAL
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 BALT
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 KANEKA CORPORATION
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 STRYKER CORPORATION
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments